108 related articles for article (PubMed ID: 15720197)
1. Dual molecules as new antimalarials.
Salom-Roig XJ; Hamzé A; Calas M; Vial HJ
Comb Chem High Throughput Screen; 2005 Feb; 8(1):49-62. PubMed ID: 15720197
[TBL] [Abstract][Full Text] [Related]
2. Mono- and bis-thiazolium salts have potent antimalarial activity.
Hamzé A; Rubi E; Arnal P; Boisbrun M; Carcel C; Salom-Roig X; Maynadier M; Wein S; Vial H; Calas M
J Med Chem; 2005 May; 48(10):3639-43. PubMed ID: 15887971
[TBL] [Abstract][Full Text] [Related]
3. Antimalarial activity of compounds interfering with Plasmodium falciparum phospholipid metabolism: comparison between mono- and bisquaternary ammonium salts.
Calas M; Ancelin ML; Cordina G; Portefaix P; Piquet G; Vidal-Sailhan V; Vial H
J Med Chem; 2000 Feb; 43(3):505-16. PubMed ID: 10669577
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of bis-thiazolium salts as potential antimalarial drugs.
Caldarelli SA; Duckert JF; Wein S; Calas M; Périgaud C; Vial H; Peyrottes S
ChemMedChem; 2010 Jul; 5(7):1102-9. PubMed ID: 20540062
[TBL] [Abstract][Full Text] [Related]
5. Development of the first oral bioprecursors of bis-alkylguanidine antimalarial drugs.
Degardin M; Wein S; Duckert JF; Maynadier M; Guy A; Durand T; Escale R; Vial H; Vo-Hoang Y
ChemMedChem; 2014 Feb; 9(2):300-4. PubMed ID: 24403182
[TBL] [Abstract][Full Text] [Related]
6. Exploration of potential prodrug approach of the bis-thiazolium salts T3 and T4 for orally delivered antimalarials.
Caldarelli SA; Boisbrun M; Alarcon K; Hamzé A; Ouattara M; Salom-Roig X; Maynadier M; Wein S; Peyrottes S; Pellet A; Calas M; Vial H
Bioorg Med Chem Lett; 2010 Jul; 20(13):3953-6. PubMed ID: 20605450
[TBL] [Abstract][Full Text] [Related]
7. The bisnaphthalimides as new active lead compounds against Plasmodium falciparum.
Tischer M; Sologub L; Pradel G; Holzgrabe U
Bioorg Med Chem; 2010 May; 18(9):2998-3003. PubMed ID: 20382538
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of amidoxime derivatives as prodrug candidates of potent bis-cationic antimalarials.
Berger O; Ortial S; Wein S; Denoyelle S; Bressolle F; Durand T; Escale R; Vial HJ; Vo-Hoang Y
Bioorg Med Chem Lett; 2019 Aug; 29(16):2203-2207. PubMed ID: 31255483
[TBL] [Abstract][Full Text] [Related]
9. Prodrugs of bisthiazolium salts are orally potent antimalarials.
Vial HJ; Wein S; Farenc C; Kocken C; Nicolas O; Ancelin ML; Bressolle F; Thomas A; Calas M
Proc Natl Acad Sci U S A; 2004 Oct; 101(43):15458-63. PubMed ID: 15492221
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of bis-alkylamidoxime O-alkylsulfonates as orally available antimalarials.
Degardin M; Wein S; Gouni S; Tran Van Ba C; Duckert JF; Durand T; Escale R; Vial H; Vo-Hoang Y
ChemMedChem; 2012 Jun; 7(6):991-1001. PubMed ID: 22544438
[TBL] [Abstract][Full Text] [Related]
11. New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo.
Soares RR; da Silva JM; Carlos BC; da Fonseca CC; de Souza LS; Lopes FV; de Paula Dias RM; Moreira PO; Abramo C; Viana GH; de Pila Varotti F; da Silva AD; Scopel KK
Bioorg Med Chem Lett; 2015 Jun; 25(11):2308-13. PubMed ID: 25920564
[TBL] [Abstract][Full Text] [Related]
12. Double-drug development against antioxidant enzymes from Plasmodium falciparum.
Biot C; Dessolin J; Grellier P; Davioud-Charvet E
Redox Rep; 2003; 8(5):280-3. PubMed ID: 14962365
[TBL] [Abstract][Full Text] [Related]
13. Potent antimalarial activity of 2-aminopyridinium salts, amidines, and guanidines.
Calas M; Ouattara M; Piquet G; Ziora Z; Bordat Y; Ancelin ML; Escale R; Vial H
J Med Chem; 2007 Dec; 50(25):6307-15. PubMed ID: 18004799
[TBL] [Abstract][Full Text] [Related]
14. Metabolites of febrifugine and its synthetic analogue by mouse liver S9 and their antimalarial activity against Plasmodium malaria parasite.
Hirai S; Kikuchi H; Kim HS; Begum K; Wataya Y; Tasaka H; Miyazawa Y; Yamamoto K; Oshima Y
J Med Chem; 2003 Sep; 46(20):4351-9. PubMed ID: 13678413
[TBL] [Abstract][Full Text] [Related]
15. Interrogating alkyl and arylalkylpolyamino (bis)urea and (bis)thiourea isosteres as potent antimalarial chemotypes against multiple lifecycle forms of Plasmodium falciparum parasites.
Verlinden BK; de Beer M; Pachaiyappan B; Besaans E; Andayi WA; Reader J; Niemand J; van Biljon R; Guy K; Egan T; Woster PM; Birkholtz LM
Bioorg Med Chem; 2015 Aug; 23(16):5131-43. PubMed ID: 25684422
[TBL] [Abstract][Full Text] [Related]
16. Protective activity of biflavanones from Garcinia kola against Plasmodium infection.
Konziase B
J Ethnopharmacol; 2015 Aug; 172():214-8. PubMed ID: 26129936
[TBL] [Abstract][Full Text] [Related]
17. Basic biochemical investigations as rationale for the design of original antimalarial drugs. An example of phospholipid metabolism.
Vial HJ; Angelin ML; Elabbadi N; Calas M; Cordinas G; Giral L
Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():251-61. PubMed ID: 1343697
[TBL] [Abstract][Full Text] [Related]
18. Commercial drugs containing flavonoids are active in mice with malaria and in vitro against chloroquine-resistant Plasmodium falciparum.
Penna-Coutinho J; Aguiar AC; Krettli/ AU
Mem Inst Oswaldo Cruz; 2018 Dec; 113(12):e180279. PubMed ID: 30540020
[TBL] [Abstract][Full Text] [Related]
19. Potent inhibitors of Plasmodium phospholipid metabolism with a broad spectrum of in vitro antimalarial activities.
Ancelin ML; Calas M; Vidal-Sailhan V; Herbuté S; Ringwald P; Vial HJ
Antimicrob Agents Chemother; 2003 Aug; 47(8):2590-7. PubMed ID: 12878524
[TBL] [Abstract][Full Text] [Related]
20. 3,5-bis(benzylidene)-4-piperidones and related N-acyl analogs: a novel cluster of antimalarials targeting the liver stage of Plasmodium falciparum.
Das U; Singh RS; Alcorn J; Hickman MR; Sciotti RJ; Leed SE; Lee PJ; Roncal N; Dimmock JR
Bioorg Med Chem; 2013 Dec; 21(23):7250-6. PubMed ID: 24139941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]